BiotechTube
Home/Neurophyxia/Drs. Elize van der Hoeven, PharmD
DE

Drs. Elize van der Hoeven, PharmD

Chief Operation Officer

Neurophyxia

Therapeutic Areas

NeurologyCardiologyNeonatology

Neurophyxia Pipeline

DrugIndicationPhase
2-iminobiotin (2-IB)Cerebral hypoxia-ischemia following StrokePhase IIb/III

Leadership Team at Neurophyxia

CP
Cacha Peeters-Scholte, MD, PhD
Co-founder & Chief Scientific Officer
IJ
Ir. Jan van der Hoeven
Chief Executive Officer
LG
Leo G. J. de Leede, PharmD, RPh, PhD
Chief Pharmaceutical Development Officer
HT
Huibert Tjabbes
Co-founder & Safety Officer
View full Neurophyxia profile